A roaring Rubius sets out to snag $1.8B market cap in $200M IPO
After closing two mega-rounds of investment within eight months of each other, a booming Rubius Therapeutics has just set terms for a $200 million IPO …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
